ClinicalTrials.Veeva

Menu

Assessment of Renal Function in Cirrhotic Patients

Baylor Scott and White Health (BSWH) logo

Baylor Scott and White Health (BSWH)

Status

Unknown

Conditions

Renal Failure
Liver Failure

Study type

Observational

Funder types

Other

Identifiers

NCT01895114
010-263

Details and patient eligibility

About

The purpose of this study is to help determine whether cystatin C is a more sensitive laboratory measurement for renal function in cirrhotic patients.

Full description

Serum cystatin C, creatinine clearance based calculations, and 125I-Iothalamate clearance (Glofil) will be obtained in 220 patients with cirrhosis. Utilizing this information, the correlation between cystatin C and 125I-Iothalamate clearance will be obtained. In addition, the current serum creatinine based calculations and true creatinine clearance will also be correlated with 125I-Iothalamate clearance. The results of this study should help to determine whether serum cystatin C is a more sensitive laboratory measurement of renal function in patients with cirrhosis.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • over 18 undergoing evaluation for a liver transplant

Exclusion criteria

  • known allergy or sensitivity to 125I-Iothalamate

Trial contacts and locations

1

Loading...

Central trial contact

Erin Fassett, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems